Nano Pharmaceuticals
Pharmaceuticals, One Discovery Drive, Rensselaer, New York, 12144, United States, 1-10 Employees
Phone Number: 51********
Who is NANOPHARMACEUTICALS
NanoPharmaceuticals (NP) has launched its first-in-human clinical trial with a novel new precision drug, NP751, that was shown to be effective in preclinical models against human glioblas...
Read More
-
Headquarters: One Discovery Drive, Rensselaer, New York, 12144, United States
-
Date Founded: 2013
-
Employees: 1-10
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
-
CEO:
James Lynch
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from NANOPHARMACEUTICALS
NanoPharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding NanoPharmaceuticals
Answer: NanoPharmaceuticals's headquarters are located at One Discovery Drive, Rensselaer, New York, 12144, United States
Answer: NanoPharmaceuticals's phone number is 51********
Answer: NanoPharmaceuticals's official website is https://nanopharmaceuticals.com
Answer: NanoPharmaceuticals's revenue is $50 Million to $100 Million
Answer: NanoPharmaceuticals's SIC: 2834
Answer: NanoPharmaceuticals's NAICS: 325412
Answer: NanoPharmaceuticals has 1-10 employees
Answer: NanoPharmaceuticals is in Pharmaceuticals
Answer: NanoPharmaceuticals contact info: Phone number: 51******** Website: https://nanopharmaceuticals.com
Answer: NanoPharmaceuticals (NP) has launched its first-in-human clinical trial with a novel new precision drug, NP751, that was shown to be effective in preclinical models against human glioblastoma (GBM) grafted into animals. The dearth of effective clinical treatment for GBM currently imposes an average survival time of nine months on patients with this cancer, only rising to 15-16 months for those receiving standard-of-care surgery and adjuvant chemotherapy. NPs Founders have conducted extensive research on a cell surface receptor for thyroid hormone on the plasma membrane, named thyrointegrin v3, that regulates a large number of intracellular signaling pathways essential to cell cycle (cell division) and cancer cell protection from self-destruction, and intercellular signaling pathways that support tumor propagation and tumor angiogenesis.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
CEO at NanoPharmaceuticals
Sign in to CIENCE GO Data to uncover contact details
Free credits every month